NovaBridge Biosciences American Depositary Shares

NBP XNAS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

200M

Short interest (Jul 15)

3.7%

Net Short (Jul 27 ): 0.0%

Borrow Fee

3.22%

↓ 2.4%

Available Shares

↑ 2.1%

Price Chart

Company Overview

NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.

Company Info

Exchange: NASDAQ

CIK: 0001778016

Asset Type: ADRC

Market Data

Market Cap: $204,697,853

Employees: 30

Status: Active

Short Interest

Current Borrow Fee 3.22%

Range: 3.00% - 3.22%

Available Shares 6M

Range: 5.5M - 6.4M

Recent Changes

Fee Change: ↑ 1.2%

Available Change: ↑ 1.8%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime